文献速递淋巴瘤

慢性淋巴细胞白血病淋巴结微环境中的代谢改变特征

Characterization of metabolic alterations of chronic lymphocytic leukemia in the lymph node microenvironment.
PubMed 文献 · Blood · 2022-01-01

研究对8例慢性淋巴细胞白血病(CLL)患者基线及伊布替尼治疗3个月后的外周血进行采样,并结合体外B细胞受体(BCR)或CD40刺激模拟淋巴结微环境,开展代谢组与转录组分析。结果显示淋巴结微环境中嘌呤、葡萄糖和谷氨酸代谢发生显著改变,CD40信号主要调控氨基酸代谢与三羧酸循环,BCR信号偏好葡萄糖和甘油代谢;谷氨酰胺是TCA循环的重要燃料,抑制谷氨酰胺转运可减轻CD40/BCR诱导的维奈克拉耐药。

要点

  • 伊布替尼治疗3个月前后外周血代谢变化与体外BCR/CD40刺激的代谢效应方向相反。
  • CD40信号主要调控氨基酸代谢、三羧酸循环和能量产生,BCR信号偏好葡萄糖和甘油代谢。
  • 谷氨酰胺是CD40/BCR刺激细胞TCA循环的重要燃料,抑制其转运可减轻维奈克拉耐药。

核心结论

  • CLL淋巴结微环境驱动嘌呤、葡萄糖和谷氨酸代谢的显著改变,氨基酸作为TCA循环燃料的突出使用提示新的治疗脆弱点。

研究设计与样本

  • 研究采用两级策略:对8例CLL患者基线及伊布替尼治疗3个月后的外周血采样,并对体外BCR或CD40刺激的细胞进行代谢组和转录组分析。
  • 对CD40/BCR刺激的细胞进行13C通量组学分析,并用V9302抑制谷氨酰胺转运。

主要发现

  • CD40信号主要调控氨基酸代谢、三羧酸循环和能量产生,BCR信号偏好葡萄糖和甘油代谢及多条生物合成途径。
  • 体外刺激与伊布替尼治疗的代谢通路分析呈现相反效应,MYC及其靶基因在BCR/CD40刺激后诱导、被伊布替尼抑制。
  • 13C通量组学证实谷氨酰胺是CD40/BCR刺激细胞TCA循环的重要燃料,葡萄糖主要转化为乳酸和核糖-5-磷酸。
  • V9302抑制谷氨酰胺转运可减弱CD40/BCR诱导的维奈克拉耐药。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Altered metabolism is a hallmark of both cell division and cancer. Chronic lymphocytic leukemia (CLL) cells circulate between peripheral blood (PB) and lymph nodes (LNs), where they receive proliferative and prosurvival signals from surrounding cells. However, insight into the metabolism of LN CLL and how this may relate to therapeutic response is lacking. To obtain insight into CLL LN metabolism, we applied a 2-tiered strategy. First, we sampled PB from 8 patients at baseline and after 3-month ibrutinib (IBR) treatment, which forces egress of CLL cells from LNs. Second, we applied in vitro B-cell receptor (BCR) or CD40 stimulation to mimic the LN microenvironment and performed metabolomic and transcriptomic analyses. The combined analyses indicated prominent changes in purine, glucose, and glutamate metabolism occurring in the LNs. CD40 signaling mostly regulated amino acid metabolism, tricarboxylic acid cycle (TCA), and energy production. BCR signaling preferably engaged glucose and glycerol metabolism and several biosynthesis routes. Pathway analyses demonstrated opposite effects of in vitro stimulation vs IBR treatment. In agreement, the metabolic regulator MYC and its target genes were induced after BCR/CD40 stimulation and suppressed by IBR. Next, 13C fluxomics performed on CD40/BCR-stimulated cells confirmed a strong contribution of glutamine as fuel for the TCA cycle, whereas glucose was mainly converted into lactate and ribose-5-phosphate. Finally, inhibition of glutamine import with V9302 attenuated CD40/BCR-induced resistance to venetoclax. Together, these data provide insight into crucial metabolic changes driven by the CLL LN microenvironment. The prominent use of amino acids as fuel for the TCA cycle suggests new therapeutic vulnerabilities.

来源:Blood,查看原文。版权归原作者所有。

引用

  1. Chen Z, Simon-Molas H, Cretenet G, et al. Characterization of metabolic alterations of chronic lymphocytic leukemia in the lymph node microenvironment. Blood. 2022. PMID: 35486832. doi:10.1182/blood.2021013990

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。